Clinical Trials Directory

Trials / Unknown

UnknownNCT05080348

Effectiveness of iPACK on Postoperative Pain From Hamstring Autograft Following ACL Repair

Effectiveness of Preoperative iPACK on Postoperative Pain From Hamstring Autograft for ACL Repair

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Brenton Alexander · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing ACL repair with hamstring autograft frequently develop significant post operative pain at the hamstring grafting site. This pain is within the distribution of a commonly used regional nerve block, the Interspace between the popliteal artery and capsule of the knee (iPACK). The investigators plan to randomize consenting patients to either receiving a SHAM injection of normal saline or to an interventional group of long acting local anesthetic (Ropivacaine) injected in the popliteal fossa between the popliteal artery and capsule of the knee (iPACK). Both groups of patients will receive standard of care with respect to perioperative pain management, which includes a preoperative adductor canal nerve block and preoperative acetaminophen administration. Dual primary endpoints of postoperative pain scores and mean postoperative opioid use will be retrieved and compared between groups. Additional secondary endpoints will be PACU length of stay, PACU opioid use, POD1 opioids use, and POD1 pain scores (best, worst, average).

Conditions

Interventions

TypeNameDescription
PROCEDURERopivacaine iPACK InjectionInjection of 20mL of 0.25% Ropivacaine with 1:400,000 Epinephrine between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles
PROCEDURENormal Saline iPACK InjectionInjection of 20mL of 0.9% Normal Saline between in the Interspace between the Popliteal Artery and the Capsule of the Knee (iPACK) using ultrasound guidance at the level of the femoral condyles

Timeline

Start date
2021-12-01
Primary completion
2022-04-01
Completion
2022-05-01
First posted
2021-10-15
Last updated
2021-10-15

Source: ClinicalTrials.gov record NCT05080348. Inclusion in this directory is not an endorsement.